The launch of United Rheumatology has been made possible by individual financial contributions from the independent rheumatology community. Initial investments in United Rheumatology were used in part to support business planning and service offering development efforts. Physicians and practice managers who wish to support United Rheumatology financially may become investors at $2,500 per equity interest. Investors are entitled to an equity stake in the company, to be determined at a later date, commensurate with the size of their investment.
To become an investor in United Rheumatology, please complete the Non-Disclosure Agreement and Subscription Agreement and mail them, along with a check payable to United Rheumatology for the amount of desired shares: